Novacyt to collaborate to validate HPV testing with NOVAprep® technology

Novacyt (ALTERNEXT: ALNOV), an international specialist in cancer and infectious disease diagnostics, has announced it will validate the NOVAprep® liquid-based cytology platform with Abbott’s RealTime High Risk HPV (Human papillomavirus) assay. Download press release

Visit Page

Novacyt Named in Deloitte Technology Fast 500

Novacyt (ALTERNEXT: ALNOV), an international specialist in cancer and infectious disease diagnostics, has been named in the Deloitte Technology Fast 500 for Europe, Middle East and Africa. Download press release

Visit Page

Novacyt Named in Deloitte Technology Fast 50

Novacyt (ALTERNEXT: ALNOV), an international specialist in cancer and infectious disease diagnostics, has been named in the Deloitte Technology Fast 50 in France. Download press release

Visit Page